{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:22:11Z","timestamp":1783441331568,"version":"3.54.6"},"reference-count":34,"publisher":"Bioscientifica","issue":"8","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":200,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2023ZD0509201"],"award-info":[{"award-number":["2023ZD0509201"]}]},{"name":"Important Disease Joint Research Project in Xuhui Health Systems of Shanghai","award":["XHLHGG202110"],"award-info":[{"award-number":["XHLHGG202110"]}]}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to explore the relationship between serum fibroblast growth factor 21 (FGF21) levels and metabolic dysfunction-associated steatotic liver disease (MASLD), and further explore the mediation effect of inflammation in their association.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included 1,710 community residents, including 697 men and 1,013 women, with a median age of 59 (55\u201363) years. Abdominal ultrasound was used to detect the liver and calculate liver fat content (LFC). MASLD was diagnosed according to the 2023 Delphi consensus. Serum FGF21 levels were measured using enzyme-linked immunosorbent assay. Inflammation levels were assessed through C-reactive protein (CRP), white blood cells (WBCs), and tumor necrosis factor-\u03b1 (TNF-\u03b1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Regardless of overweight\/obese status, serum FGF21 levels were higher in individuals with MASLD than in individuals without MASLD (all P &amp;lt; 0.05). In the multivariate logistic regression model, for every 1-unit increase in serum FGF21 levels, the risk of MASLD was 1.46 (95% confidence interval (CI), 1.11\u20131.92) and 1.51 (95% CI, 1.19\u20131.93) in lean and overweight\/obesity subjects, respectively. Moreover, serum FGF21 levels were positively correlated with LFC (P &amp;lt; 0.05), and the relationship between serum FGF21 and LFC could be partially mediated by CRP, WBC, and TNF-\u03b1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Regardless of overweight\/obese status, serum FGF21 levels were significantly associated with an elevated risk of MASLD. Furthermore, serum FGF21 levels were independently associated with LFC, which could be partially mediated by inflammation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/ec-25-0351","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T11:22:29Z","timestamp":1753442549000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":2,"title":["Associations among serum FGF21 levels, inflammation, and metabolic dysfunction-associated steatotic liver disease: mediation analyses in a Chinese community-based population"],"prefix":"10.1530","volume":"14","author":[{"given":"Hongyu","family":"Tan","sequence":"first","affiliation":[{"name":"Jinzhou Medical University Graduate Training Base, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine 1 , ,","place":["Shanghai, China"]},{"name":"Department of Endocrinology and Metabolism, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute 2 , ,","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute 2 , ,","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhui","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute 2 , ,","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute 2 , ,","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute 2 , ,","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute 2 , ,","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4754-3470","authenticated-orcid":true,"given":"Yuqian","family":"Bao","sequence":"additional","affiliation":[{"name":"Jinzhou Medical University Graduate Training Base, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine 1 , ,","place":["Shanghai, China"]},{"name":"Department of Endocrinology and Metabolism, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute 2 , ,","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"2026070711014915100_bib1","volume-title":"World Obesity Atlas 2023","author":"World Obesity Federation"},{"key":"2026070711014915100_bib2","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/ajcn\/34.8.1617","article-title":"The \u201cmetabolically-obese,\u201d normal-weight individual","volume":"34","author":"Ruderman","year":"1981","journal-title":"Am J Clin Nutr"},{"key":"2026070711014915100_bib3","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"key":"2026070711014915100_bib4","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"2026070711014915100_bib5","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"2026070711014915100_bib6","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.cmet.2013.04.005","article-title":"Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice","volume":"17","author":"Lin","year":"2013","journal-title":"Cell Metab"},{"key":"2026070711014915100_bib7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.metabol.2014.11.009","article-title":"The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy","volume":"64","author":"Liu","year":"2015","journal-title":"Metabolism"},{"key":"2026070711014915100_bib8","doi-asserted-by":"crossref","first-page":"29751","DOI":"10.1074\/jbc.M114.565960","article-title":"Fibroblast growth factor 21 is regulated by the IRE1\u03b1-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis","volume":"289","author":"Jiang","year":"2014","journal-title":"J Biol Chem"},{"key":"2026070711014915100_bib9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41467-017-02677-9","article-title":"Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat","volume":"9","author":"Li","year":"2018","journal-title":"Nat Commun"},{"key":"2026070711014915100_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156318","article-title":"Insight to the association among fibroblast growth factor 21, non-alcoholic fatty liver disease and cardiovascular outcomes: a population-based study","volume":"170","author":"Shen","year":"2023","journal-title":"Cytokine"},{"key":"2026070711014915100_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/clinem\/dgae531","article-title":"Association of initial and changes in serum A-FABP level with the development and improvement of Presarcopenia","volume":"110","author":"Hu","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070711014915100_bib12","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1210\/clinem\/dgad110","article-title":"The association and Joint effect of adipocyte fatty acid binding protein and obesity phenotype with cardiovascular events","volume":"108","author":"Hu","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070711014915100_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2026070711014915100_bib14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/oby.2011.302","article-title":"Standardized ultrasound hepatic\/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method","volume":"20","author":"Xia","year":"2012","journal-title":"Obesity"},{"key":"2026070711014915100_bib15","volume-title":"Guidelines for the Conduct of Tobacco Smoking Surveys for the General Population","author":"World Health Organization","year":"1983"},{"key":"2026070711014915100_bib16","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"2026070711014915100_bib17","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/HJH.0000000000002453","article-title":"2020 International society of hypertension global hypertension practice guidelines","volume":"38","author":"Unger","year":"2020","journal-title":"J Hypertens"},{"key":"2026070711014915100_bib18","first-page":"221","article-title":"Chinese lipid management guidelines (2023)","volume":"3","author":"Joint Committee on the Chinese Guidelines for Lipid Management","year":"2023","journal-title":"Chin J Cardiol"},{"key":"2026070711014915100_bib19","volume-title":"Adult body weight determination (WS\/T 428-2013)","author":"National Health Commission of the People\u2019s Republic of China"},{"key":"2026070711014915100_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/0163278718819708","article-title":"Validity of the international physical activity questionnaire-short form for application in Asian countries: a study in Vietnam","volume":"43","author":"Tran","year":"2020","journal-title":"Eval Health Prof"},{"key":"2026070711014915100_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S2213-8587(19)30425-5","article-title":"Association of insulin resistance and \u03b2-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study","volume":"8","author":"Wang","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026070711014915100_bib22","volume-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","edition":"10th Edn"},{"key":"2026070711014915100_bib23","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2362.2010.02338.x","article-title":"Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease","volume":"40","author":"Yilmaz","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"2026070711014915100_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2020.101221","article-title":"Dose-response relationship between serum fibroblast growth factor 21 and liver fat content in non-alcoholic fatty liver disease","volume":"47","author":"Xiao","year":"2021","journal-title":"Diabetes Metab"},{"key":"2026070711014915100_bib25","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1038\/s41598-017-05257-5","article-title":"Complementary role of fibroblast growth factor 21 and cytokeratin 18 in monitoring the different stages of nonalcoholic fatty liver disease","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"2026070711014915100_bib26","first-page":"350","article-title":"[A prospective study of serum fibroblast growth factor 21 changes in nonalcoholic fatty liver patients]","volume":"23","author":"Zhan","year":"2015","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"2026070711014915100_bib27","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1002\/hep4.2081","article-title":"Outcomes of subjects who are lean, overweight or obese with nonalcoholic fatty liver disease: a cohort study in China","volume":"6","author":"Lan","year":"2022","journal-title":"Hepatol Commun"},{"key":"2026070711014915100_bib28","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12072-021-10143-4","article-title":"The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995\u20132040","volume":"15","author":"Ito","year":"2021","journal-title":"Hepatol Int"},{"key":"2026070711014915100_bib29","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"2026070711014915100_bib30","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"2026070711014915100_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.153994","article-title":"Fibroblast growth factor 21 in non-alcoholic fatty liver disease","volume":"101","author":"Tucker","year":"2019","journal-title":"Metabolism"},{"key":"2026070711014915100_bib32","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1111\/bph.14383","article-title":"A long-acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis partly through an FGF21-adiponectin-IL17A pathway","volume":"175","author":"Bao","year":"2018","journal-title":"Br J Pharmacol"},{"key":"2026070711014915100_bib33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1148\/radiol.10091790","article-title":"Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy","volume":"256","author":"van Werven","year":"2010","journal-title":"Radiology"},{"key":"2026070711014915100_bib34","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","article-title":"Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study","volume":"51","author":"Dasarathy","year":"2009","journal-title":"J Hepatol"}],"container-title":["Endocrine Connections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/14\/8\/EC-25-0351.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/14\/8\/EC-25-0351.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-25-0351\/9933\/ec-25-0351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-25-0351\/9933\/ec-25-0351.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:37:10Z","timestamp":1783438630000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article\/14\/8\/e250351\/1457\/Associations-among-serum-FGF21-levels-inflammation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1530\/ec-25-0351","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"article-number":"e250351"}}